DELFT, NETHERLANDS: Evonik Industries and Royal DSM NV have established a new company, Veramaris VOF, for the production of omega-3 fatty acids EPA and DHA from natural marine algae for animal nutrition.
The 50:50 joint venture is headquartered at the DSM Biotech Campus in Delft, Netherlands.
Veramaris’s breakthrough innovation – an algal oil – will, for the first time, enable the production of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) for animal nutrition without using fish oil from wild-caught fish, a finite resource. DSM and Evonik announced their intention to start this joint venture in March 2017.
Construction of the $200 million production facility at the Evonik site in Blair, Nebraska (US), has commenced and is proceeding according to plan. Commercial quantities of the algal oil rich in the essential omega-3 fatty acids EPA and DHA will be ready for sale in 2019. Pilot quantities for market development purposes are already available. The initial annual production capacity will meet roughly 15 percent of the total current annual demand for EPA and DHA by the salmon aquaculture industry.
No comments:
Post a Comment